Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

US Food and Drug Administration Efforts to Support Pain Management and Opioid Access to Patients With Cancer.

Hertz SH, Throckmorton DC.

J Oncol Pract. 2019 May;15(5):233-234. doi: 10.1200/JOP.19.00143. Epub 2019 Apr 23. No abstract available.

PMID:
31013179
2.

Analysis of current financial relationships between emergency physicians and industry.

Niforatos JD, Boas S, Hertz S, Ozgur A, Raja AS.

Am J Emerg Med. 2019 Apr;37(4):722-725. doi: 10.1016/j.ajem.2018.12.039. Epub 2018 Dec 29.

PMID:
30611579
3.

Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors of BTBR mice.

Perets N, Hertz S, London M, Offen D.

Mol Autism. 2018 Nov 21;9:57. doi: 10.1186/s13229-018-0240-6. eCollection 2018.

4.

Gender and Compensation: Understanding the Impact of Gender and Gender Stereotypes in Children's Rewards.

Hertz SG, Wood E, Gilbert J, Victor R, Anderson E, Desmarais S.

J Genet Psychol. 2018 Sep-Oct;179(5):311-323. doi: 10.1080/00221325.2018.1512077. Epub 2018 Oct 26.

PMID:
30362907
5.

Medication development in opioid addiction: Meaningful clinical end points.

Volkow ND, Woodcock J, Compton WM, Throckmorton DC, Skolnick P, Hertz S, Wargo EM.

Sci Transl Med. 2018 Mar 28;10(434). pii: eaan2595. doi: 10.1126/scitranslmed.aan2595. Review.

PMID:
29593105
6.

Attachment Security and Developmental Patterns of Growth in Executive Functioning During Early Elementary School.

Matte-Gagné C, Bernier A, Sirois MS, Lalonde G, Hertz S.

Child Dev. 2018 May;89(3):e167-e182. doi: 10.1111/cdev.12807. Epub 2017 May 29.

PMID:
28556965
7.

Long term beneficial effect of neurotrophic factors-secreting mesenchymal stem cells transplantation in the BTBR mouse model of autism.

Perets N, Segal-Gavish H, Gothelf Y, Barzilay R, Barhum Y, Abramov N, Hertz S, Morozov D, London M, Offen D.

Behav Brain Res. 2017 Jul 28;331:254-260. doi: 10.1016/j.bbr.2017.03.047. Epub 2017 Apr 7.

PMID:
28392323
8.

Use of Imaging in Children With Witnessed Physical Abuse.

Melville JD, Hertz SK, Steiner RD, Lindberg DM; ExSTRA Investigators.

Pediatr Emerg Care. 2019 Apr;35(4):245-248. doi: 10.1097/PEC.0000000000001096.

PMID:
28291153
9.

Social Ultrasonic Vocalization in Awake Head-Restrained Mouse.

Weiner B, Hertz S, Perets N, London M.

Front Behav Neurosci. 2016 Dec 19;10:236. doi: 10.3389/fnbeh.2016.00236. eCollection 2016.

10.

Orbital complications associated with paranasal sinus infections - A 10-year experience in Israel.

Segal N, Nissani R, Kordeluk S, Holcberg M, Hertz S, Kassem F, Mansour A, Segal A, Gluck O, Roth Y, Honigman T, Ephros M, Cohen Kerem R.

Int J Pediatr Otorhinolaryngol. 2016 Jul;86:60-2. doi: 10.1016/j.ijporl.2016.04.016. Epub 2016 Apr 25.

PMID:
27260581
11.

The GAS trial.

Orser BA, Evers AS, Suresh S, Hertz S.

Lancet. 2016 Apr 16;387(10028):1613-4. doi: 10.1016/S0140-6736(16)30199-4. Epub 2016 Apr 14. No abstract available.

PMID:
27116066
12.

Anesthetic neurotoxicity--clinical implications of animal models.

Rappaport BA, Suresh S, Hertz S, Evers AS, Orser BA.

N Engl J Med. 2015 Feb 26;372(9):796-7. doi: 10.1056/NEJMp1414786.

PMID:
25714157
13.

Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review.

Hunsinger M, Smith SM, Rothstein D, McKeown A, Parkhurst M, Hertz S, Katz NP, Lin AH, McDermott MP, Rappaport BA, Turk DC, Dworkin RH.

Pain. 2014 Nov;155(11):2253-62. doi: 10.1016/j.pain.2014.08.004. Epub 2014 Aug 12. Review.

PMID:
25123543
14.

Children's utilization of emotion expectancies in moral decision-making.

Hertz SG, Krettenauer T.

Br J Dev Psychol. 2014 Sep;32(3):367-73. doi: 10.1111/bjdp.12052. Epub 2014 Jun 24.

PMID:
24961286
15.

Using breakthrough series collaborative methodology to improve safe delivery of chemotherapy in Ontario.

Simanovski V, Green E, Meertens E, Kaizer L, Ahmad N, Hertz S, Cheng R, Burns J, Krzyzanowska MK.

J Oncol Pract. 2014 Jul;10(4):e240-6. doi: 10.1200/JOP.2013.001254. Epub 2014 Apr 8.

PMID:
24715267
16.

Oral chemotherapy practices at Ontario cancer centres.

Ahmad N, Simanovski V, Hertz S, Klaric G, Kaizer L, Krzyzanowska MK.

J Oncol Pharm Pract. 2015 Aug;21(4):249-57. doi: 10.1177/1078155214528830. Epub 2014 Apr 8.

PMID:
24714129
17.

The ACTTION-American Pain Society Pain Taxonomy (AAPT): an evidence-based and multidimensional approach to classifying chronic pain conditions.

Fillingim RB, Bruehl S, Dworkin RH, Dworkin SF, Loeser JD, Turk DC, Widerstrom-Noga E, Arnold L, Bennett R, Edwards RR, Freeman R, Gewandter J, Hertz S, Hochberg M, Krane E, Mantyh PW, Markman J, Neogi T, Ohrbach R, Paice JA, Porreca F, Rappaport BA, Smith SM, Smith TJ, Sullivan MD, Verne GN, Wasan AD, Wesselmann U.

J Pain. 2014 Mar;15(3):241-9. doi: 10.1016/j.jpain.2014.01.004.

18.

Reporting of primary analyses and multiplicity adjustment in recent analgesic clinical trials: ACTTION systematic review and recommendations.

Gewandter JS, Smith SM, McKeown A, Burke LB, Hertz SH, Hunsinger M, Katz NP, Lin AH, McDermott MP, Rappaport BA, Williams MR, Turk DC, Dworkin RH.

Pain. 2014 Mar;155(3):461-6. doi: 10.1016/j.pain.2013.11.009. Epub 2013 Nov 23. Review.

PMID:
24275257
19.

Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.

O'Connor AB, Turk DC, Dworkin RH, Katz NP, Colucci R, Haythornthwaite JA, Klein M, O'Brien C, Posner K, Rappaport BA, Reisfield G, Adams EH, Balster RL, Bigelow GE, Burke LB, Comer SD, Cone E, Cowan P, Denisco RA, Farrar JT, Foltin RW, Haddox JD, Hertz S, Jay GW, Junor R, Kopecky EA, Leiderman DB, McDermott MP, Palmer PP, Raja SN, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Smith SM, Sokolowska M, Stauffer JW, Walsh SL, Zacny JP.

Pain. 2013 Nov;154(11):2324-34. doi: 10.1016/j.pain.2013.06.035. Review.

PMID:
24148704
20.

Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations.

Smith SM, Wang AT, Pereira A, Chang RD, McKeown A, Greene K, Rowbotham MC, Burke LB, Coplan P, Gilron I, Hertz SH, Katz NP, Lin AH, McDermott MP, Papadopoulos EJ, Rappaport BA, Sweeney M, Turk DC, Dworkin RH.

Pain. 2013 Dec;154(12):2769-74. doi: 10.1016/j.pain.2013.08.011. Epub 2013 Aug 17. Review.

PMID:
23962590
21.

Use of continuous infusion pumps during radiation treatment.

Bak K, Gutierrez E, Lockhart E, Sharpe M, Green E, Costa S, Hertz S, Kaizer L, Whitton A, Warde P.

J Oncol Pract. 2013 Mar;9(2):107-11. doi: 10.1200/JOP.2012.000717. Review.

22.

Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations.

Smith SM, Wang AT, Katz NP, McDermott MP, Burke LB, Coplan P, Gilron I, Hertz SH, Lin AH, Rappaport BA, Rowbotham MC, Sampaio C, Sweeney M, Turk DC, Dworkin RH.

Pain. 2013 Jul;154(7):997-1008. doi: 10.1016/j.pain.2013.03.003. Epub 2013 Mar 14.

PMID:
23602344
23.

Regulatory review of acetaminophen clinical pharmacology in young pediatric patients.

Ji P, Wang Y, Li Z, Doddapaneni S, Hertz S, Furness S, Sahajwalla CG.

J Pharm Sci. 2012 Dec;101(12):4383-9. doi: 10.1002/jps.23331. Epub 2012 Oct 16. Review.

PMID:
23073837
24.

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations.

Comer SD, Zacny JP, Dworkin RH, Turk DC, Bigelow GE, Foltin RW, Jasinski DR, Sellers EM, Adams EH, Balster R, Burke LB, Cerny I, Colucci RD, Cone E, Cowan P, Farrar JT, Haddox JD, Haythornthwaite JA, Hertz S, Jay GW, Johanson CE, Junor R, Katz NP, Klein M, Kopecky EA, Leiderman DB, McDermott MP, O'Brien C, O'Connor AB, Palmer PP, Raja SN, Rappaport BA, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Sokolowska M, Stauffer JW, Walsh SL.

Pain. 2012 Dec;153(12):2315-24. doi: 10.1016/j.pain.2012.07.035. Epub 2012 Sep 19.

25.

Determining resource intensity weights in ambulatory chemotherapy related to nursing workload.

Green E, Preyra C, Stewart J, McLennan C, Bland R, Dus T, Langhorn M, Beattie K, Cheung A, Hertz S, Sechter H, Burns J, Angus H, Sawka C.

Can Oncol Nurs J. 2012 Spring;22(2):114-28. Review. English, French.

PMID:
22764587
26.

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, Gilron I, Jensen MP, Katz NP, Raja SN, Rappaport BA, Rowbotham MC, Backonja MM, Baron R, Bellamy N, Bhagwagar Z, Costello A, Cowan P, Fang WC, Hertz S, Jay GW, Junor R, Kerns RD, Kerwin R, Kopecky EA, Lissin D, Malamut R, Markman JD, McDermott MP, Munera C, Porter L, Rauschkolb C, Rice AS, Sampaio C, Skljarevski V, Sommerville K, Stacey BR, Steigerwald I, Tobias J, Trentacosti AM, Wasan AD, Wells GA, Williams J, Witter J, Ziegler D.

Pain. 2012 Jun;153(6):1148-58. doi: 10.1016/j.pain.2012.03.003. Epub 2012 Apr 9.

PMID:
22494920
27.

A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa.

Kafantaris V, Leigh E, Hertz S, Berest A, Schebendach J, Sterling WM, Saito E, Sunday S, Higdon C, Golden NH, Malhotra AK.

J Child Adolesc Psychopharmacol. 2011 Jun;21(3):207-12. doi: 10.1089/cap.2010.0139.

PMID:
21663423
28.

Key components of intravenous chemotherapy labeling: a systematic review and practice guideline.

Trudeau M, Green E, Cosby R, Charbonneau F, Easty T, Ko Y, Marchand P, David U, Berger N, Hertz S.

J Oncol Pharm Pract. 2011 Dec;17(4):409-24. doi: 10.1177/1078155210385160. Epub 2010 Sep 27. Review.

PMID:
20876081
29.

Endovascular treatment of a pseudoaneurysm after an iatrogenic axillary artery injury.

Weger N, Klaassen Z, Sturt C, Hertz S.

Ann Vasc Surg. 2010 Aug;24(6):826.e9-12. doi: 10.1016/j.avsg.2009.12.019. Epub 2010 May 13.

PMID:
20471203
30.

Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, Chappell A, Chartier K, Cleeland CS, Costello A, Cowan P, Dimitrova R, Ellenberg S, Farrar JT, French JA, Gilron I, Hertz S, Jadad AR, Jay GW, Kalliomäki J, Katz NP, Kerns RD, Manning DC, McDermott MP, McGrath PJ, Narayana A, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Reeve BB, Rhodes T, Sampaio C, Simpson DM, Stauffer JW, Stucki G, Tobias J, White RE, Witter J.

Pain. 2010 May;149(2):177-93. doi: 10.1016/j.pain.2010.02.018. Epub 2010 Mar 6. Review.

PMID:
20207481
31.

Placebo and treatment group responses in postherpetic neuralgia vs. painful diabetic peripheral neuropathy clinical trials in the REPORT database.

Dworkin RH, Turk DC, Peirce-Sandner S, McDermott MP, Farrar JT, Hertz S, Katz NP, Raja SN, Rappaport BA.

Pain. 2010 Jul;150(1):12-6. doi: 10.1016/j.pain.2010.02.002. Epub 2010 Mar 3. Review. No abstract available.

PMID:
20202753
32.

Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, Farrar JT, Hertz S, Raja SN, Rappaport BA, Rauschkolb C, Sampaio C.

Pain. 2009 Dec;146(3):238-44. doi: 10.1016/j.pain.2009.08.019. Review.

PMID:
19836888
33.

Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2).

Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Melzack R.

Pain. 2009 Jul;144(1-2):35-42. doi: 10.1016/j.pain.2009.02.007. Epub 2009 Apr 7.

PMID:
19356853
34.

Metabolic assessment of menstruating and nonmenstruating normal weight adolescents.

Sterling WM, Golden NH, Jacobson MS, Ornstein RM, Hertz SM.

Int J Eat Disord. 2009 Nov;42(7):658-63. doi: 10.1002/eat.20604.

PMID:
19247996
35.

Losses of chromosome arms 4q, 8p, 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma.

Hertz S, Rothämel T, Skawran B, Giere C, Steinemann D, Flemming P, Becker T, Flik J, Wiese B, Soudah B, Kreipe H, Schlegelberger B, Wilkens L.

Pathobiology. 2008;75(5):312-22. doi: 10.1159/000151712. Epub 2008 Oct 15.

36.

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials.

Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad AR, Jay GW, Jermano JA, Katz NP, Manning DC, Martin S, Max MB, McGrath P, McQuay HJ, Quessy S, Rappaport BA, Revicki DA, Rothman M, Stauffer JW, Svensson O, White RE, Witter J.

Pain. 2008 Oct 31;139(3):485-93. doi: 10.1016/j.pain.2008.06.025. Epub 2008 Aug 15. Review.

PMID:
18706763
37.

Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations.

McGrath PJ, Walco GA, Turk DC, Dworkin RH, Brown MT, Davidson K, Eccleston C, Finley GA, Goldschneider K, Haverkos L, Hertz SH, Ljungman G, Palermo T, Rappaport BA, Rhodes T, Schechter N, Scott J, Sethna N, Svensson OK, Stinson J, von Baeyer CL, Walker L, Weisman S, White RE, Zajicek A, Zeltzer L; PedIMMPACT.

J Pain. 2008 Sep;9(9):771-83. doi: 10.1016/j.jpain.2008.04.007. Epub 2008 Jun 17.

PMID:
18562251
38.

Treatment goal weight in adolescents with anorexia nervosa: use of BMI percentiles.

Golden NH, Jacobson MS, Sterling WM, Hertz S.

Int J Eat Disord. 2008 May;41(4):301-6. doi: 10.1002/eat.20503.

PMID:
18176951
39.

[Collaboration patients-health care providers].

Grezet-Bento de Carvalho A, Griesser AC, Hertz S, Constantin M, Forni M, Blagojevic S, Bouchardy C, Vlastos G.

Rev Med Suisse. 2007 Oct 24;3(130):2418-20, 2422-3. French.

PMID:
18062506
40.

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA, Rauschkolb C, Revicki DA, Rothman M, Schmader KE, Stacey BR, Stauffer JW, von Stein T, White RE, Witter J, Zavisic S.

J Pain. 2008 Feb;9(2):105-21. Epub 2007 Dec 11.

PMID:
18055266
41.

Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain.

Turk DC, Dworkin RH, Revicki D, Harding G, Burke LB, Cella D, Cleeland CS, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA.

Pain. 2008 Jul 15;137(2):276-85. Epub 2007 Oct 15.

PMID:
17937976
42.

Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations.

Turk DC, Dworkin RH, Burke LB, Gershon R, Rothman M, Scott J, Allen RR, Atkinson JH, Chandler J, Cleeland C, Cowan P, Dimitrova R, Dionne R, Farrar JT, Haythornthwaite JA, Hertz S, Jadad AR, Jensen MP, Kellstein D, Kerns RD, Manning DC, Martin S, Max MB, McDermott MP, McGrath P, Moulin DE, Nurmikko T, Quessy S, Raja S, Rappaport BA, Rauschkolb C, Robinson JP, Royal MA, Simon L, Stauffer JW, Stucki G, Tollett J, von Stein T, Wallace MS, Wernicke J, White RE, Williams AC, Witter J, Wyrwich KW; Initiative on Methods, Measurement and Pain Assessment in Clinical Trials.

Pain. 2006 Dec 5;125(3):208-15. Epub 2006 Oct 25. No abstract available.

PMID:
17069973
43.

Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.

Steinemann D, Skawran B, Becker T, Tauscher M, Weigmann A, Wingen L, Tauscher S, Hinrichsen T, Hertz S, Flemming P, Flik J, Wiese B, Kreipe H, Lichter P, Schlegelberger B, Wilkens L.

Clin Gastroenterol Hepatol. 2006 Oct;4(10):1283-91. Epub 2006 Sep 18.

PMID:
16979954
44.

Pediatric drug development in anesthesiology: an FDA perspective.

Schultheis LW, Mathis LL, Roca RA, Simone AF, Hertz SH, Rappaport BA.

Anesth Analg. 2006 Jul;103(1):49-51. No abstract available.

PMID:
16790624
45.

Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial.

Golden NH, Iglesias EA, Jacobson MS, Carey D, Meyer W, Schebendach J, Hertz S, Shenker IR.

J Clin Endocrinol Metab. 2005 Jun;90(6):3179-85. Epub 2005 Mar 22.

PMID:
15784715
46.

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.

Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT.

Pain. 2005 Jan;113(1-2):9-19. Review. No abstract available.

PMID:
15621359
47.

Prophylactic antibiotics prior to bacteremia decrease endovascular graft infection in dogs.

Kirksey L, Brener BJ, Hertz S, Parsonnet V.

Vasc Endovascular Surg. 2002 May-Jun;36(3):171-8.

PMID:
12075382
48.

An in situ adjustable endovascular graft for the treatment of abdominal aortic aneurysms.

Brener BJ, Faries P, Connelly T, Sefranek V, Hertz S, Kirksey L, Hollier L, Marin ML.

J Vasc Surg. 2002 Jan;35(1):114-9.

49.

Combined off-pump myocardial revascularization and carotid endarterectomy: early experience.

Youssuf AM, Karanam R, Prendergast T, Brener B, Hertz S, Saunders CR, Goldstein DJ.

Ann Thorac Surg. 2001 Nov;72(5):1542-5.

PMID:
11722040
50.

Genome scan of idiopathic generalized epilepsy: evidence for major susceptibility gene and modifying genes influencing the seizure type.

Durner M, Keddache MA, Tomasini L, Shinnar S, Resor SR, Cohen J, Harden C, Moshe SL, Rosenbaum D, Kang H, Ballaban-Gil K, Hertz S, Labar DR, Luciano D, Wallace S, Yohai D, Klotz I, Dicker E, Greenberg DA.

Ann Neurol. 2001 Mar;49(3):328-35.

PMID:
11261507

Supplemental Content

Support Center